Amylin, Alkermes Find Relief in Benign FDA Response Letter to Diabetes Drug - Seeking Alpha (blog)

dBTechno

Amylin, Alkermes Find Relief in Benign FDA Response Letter to Diabetes Drug Seeking Alpha (blog) ... Alkermes and co-partner Eli Lilly's (LLY) once-weekly version (Bydureon/Byetta LAR) of the already approved twice-daily diabetes therapy, Byetta, ... FDA Rejects Amylin Diabetes Drug, Seeks More InfoWall Street Journal Amylin shares up on FDA response for diabetes drugThe Associated Press Alkermes, others rise on Byetta newsBoston Globe Forbes -AboutLawsuits.com -Cincinnati.com all 258 news articles »

Diabetes: Do You Have It? Will You Get It? Find Out Now! - Huffington Post (blog)

Tampa Tribune

Diabetes: Do You Have It? Will You Get It? Find Out Now! Huffington Post (blog) March 23rd is Diabetes Alert Day. It's a one day "wake-up" call, sponsored by the American Diabetes Association (ADA), for Americans to see if they have ... Arthritis drug shows promise in Type 2 diabetes studyBoston Globe Salsalate May Help Treat Type 2 DiabetesWebMD Generic shows promise in aiding type 2 diabetes treatmentTampa Tribune DrugWatch.com -TopNews United States -Times of India all 61 news articles »

Aggressive Treatments Don't Help Diabetes Patients - WebMD

ABC News

Aggressive Treatments Don't Help Diabetes Patients WebMD But for individual people with diabetes, the findings brought some good news in that the current standard of care worked better than expected, some doctors ... Diabetes Trial: Drug Treatment May Not Cut Heart DiseaseTIME To Cut Diabetes Heart Risks, Diet and Exercise May Beat DrugsU.S. News & World Report ACCORD, NAVIGATOR trial results disappoint on heart risk in diabetesPharma Times HealthandAge.com -Zenopa -Tucson Citizen all 128 news articles »

Mylan, Takeda reach agreement over diabetes drugs - BusinessWeek

Mylan, Takeda reach agreement over diabetes drugs BusinessWeek ... reached settlement agreements with Japanese drugmaker Takeda Pharmaceuticals over rights to launch generic versions of two Type 2 diabetes treatments. ... Mylan Enters Into Settlement Agreements With Takeda Pharma For Type 2 Diabetes ...RTT News all 26 news articles »

MannKind's Diabetes Device Under More Clouds - TheStreet.com

MannKind's Diabetes Device Under More Clouds TheStreet.com The company is required to submit data to FDA showing how Afrezza is to be used, by which diabetes patients in particular, and when the device's use is best ... FDA Requests More Info on MannKind's Diabetes Inhalant DrugFOXBusiness MannKind Falls After FDA Requests More Info On Diabetes DrugWall Street Journal FDA issues complete response letter for MannKind's AfrezzaDrug Store News MarketWatch (press release) -BioWorld Online -Forbes all 86 news articles »